vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and TechnipFMC plc (FTI). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $2.5B, roughly 1.2× TechnipFMC plc). Quest Diagnostics runs the higher net margin — 9.7% vs 9.6%, a 0.1% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs 6.3%). Over the past eight quarters, TechnipFMC plc's revenue compounded faster (11.0% CAGR vs 9.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

TechnipFMC plc is a French-American, UK-domiciled global oil and gas company that provides services for the energy industry. The company was formed by the merger of FMC Technologies of the United States and Technip of France that was announced in 2016 and completed in 2017.

DGX vs FTI — Head-to-Head

Bigger by revenue
DGX
DGX
1.2× larger
DGX
$2.9B
$2.5B
FTI
Growing faster (revenue YoY)
DGX
DGX
+2.8% gap
DGX
9.2%
6.3%
FTI
Higher net margin
DGX
DGX
0.1% more per $
DGX
9.7%
9.6%
FTI
Faster 2-yr revenue CAGR
FTI
FTI
Annualised
FTI
11.0%
9.9%
DGX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGX
DGX
FTI
FTI
Revenue
$2.9B
$2.5B
Net Profit
$281.0M
$242.7M
Gross Margin
Operating Margin
15.4%
12.6%
Net Margin
9.7%
9.6%
Revenue YoY
9.2%
6.3%
Net Profit YoY
12.0%
8.0%
EPS (diluted)
$2.24
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
FTI
FTI
Q1 26
$2.9B
Q4 25
$2.8B
$2.5B
Q3 25
$2.8B
$2.6B
Q2 25
$2.8B
$2.5B
Q1 25
$2.7B
$2.2B
Q4 24
$2.6B
$2.4B
Q3 24
$2.5B
$2.3B
Q2 24
$2.4B
$2.3B
Net Profit
DGX
DGX
FTI
FTI
Q1 26
$281.0M
Q4 25
$245.0M
$242.7M
Q3 25
$245.0M
$309.7M
Q2 25
$282.0M
$269.5M
Q1 25
$220.0M
$142.0M
Q4 24
$222.0M
$224.7M
Q3 24
$226.0M
$274.6M
Q2 24
$229.0M
$186.5M
Gross Margin
DGX
DGX
FTI
FTI
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
23.1%
Q1 25
32.5%
20.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
21.2%
Operating Margin
DGX
DGX
FTI
FTI
Q1 26
15.4%
Q4 25
13.8%
12.6%
Q3 25
13.7%
16.5%
Q2 25
15.9%
15.9%
Q1 25
13.0%
12.5%
Q4 24
13.8%
11.3%
Q3 24
13.3%
13.7%
Q2 24
14.8%
13.3%
Net Margin
DGX
DGX
FTI
FTI
Q1 26
9.7%
Q4 25
8.7%
9.6%
Q3 25
8.7%
11.7%
Q2 25
10.2%
10.6%
Q1 25
8.3%
6.4%
Q4 24
8.5%
9.5%
Q3 24
9.1%
11.7%
Q2 24
9.6%
8.0%
EPS (diluted)
DGX
DGX
FTI
FTI
Q1 26
$2.24
Q4 25
$2.18
$0.58
Q3 25
$2.16
$0.75
Q2 25
$2.47
$0.64
Q1 25
$1.94
$0.33
Q4 24
$1.95
$0.51
Q3 24
$1.99
$0.63
Q2 24
$2.03
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
FTI
FTI
Cash + ST InvestmentsLiquidity on hand
$393.0M
$1.0B
Total DebtLower is stronger
$5.7B
$430.0M
Stockholders' EquityBook value
$7.7B
$3.4B
Total Assets
$16.7B
$10.1B
Debt / EquityLower = less leverage
0.74×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
FTI
FTI
Q1 26
$393.0M
Q4 25
$420.0M
$1.0B
Q3 25
$432.0M
$876.6M
Q2 25
$319.0M
$950.0M
Q1 25
$188.0M
$1.2B
Q4 24
$549.0M
$1.2B
Q3 24
$764.0M
Q2 24
$271.0M
Total Debt
DGX
DGX
FTI
FTI
Q1 26
$5.7B
Q4 25
$5.2B
$430.0M
Q3 25
$5.2B
$438.0M
Q2 25
$5.2B
$696.3M
Q1 25
$5.9B
$904.9M
Q4 24
$5.6B
$885.2M
Q3 24
$5.6B
$966.7M
Q2 24
$3.8B
$968.4M
Stockholders' Equity
DGX
DGX
FTI
FTI
Q1 26
$7.7B
Q4 25
$7.2B
$3.4B
Q3 25
$7.3B
$3.3B
Q2 25
$7.2B
$3.3B
Q1 25
$6.9B
$3.1B
Q4 24
$6.8B
$3.1B
Q3 24
$6.8B
$3.3B
Q2 24
$6.6B
$3.0B
Total Assets
DGX
DGX
FTI
FTI
Q1 26
$16.7B
Q4 25
$16.2B
$10.1B
Q3 25
$16.2B
$10.3B
Q2 25
$16.0B
$10.1B
Q1 25
$15.8B
$10.0B
Q4 24
$16.2B
$9.9B
Q3 24
$16.1B
$9.7B
Q2 24
$13.9B
$9.2B
Debt / Equity
DGX
DGX
FTI
FTI
Q1 26
0.74×
Q4 25
0.72×
0.13×
Q3 25
0.71×
0.13×
Q2 25
0.72×
0.21×
Q1 25
0.85×
0.29×
Q4 24
0.83×
0.29×
Q3 24
0.83×
0.30×
Q2 24
0.58×
0.33×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
FTI
FTI
Operating Cash FlowLast quarter
$278.0M
$453.6M
Free Cash FlowOCF − Capex
$359.1M
FCF MarginFCF / Revenue
14.3%
Capex IntensityCapex / Revenue
3.9%
3.8%
Cash ConversionOCF / Net Profit
0.99×
1.87×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
FTI
FTI
Q1 26
$278.0M
Q4 25
$465.0M
$453.6M
Q3 25
$563.0M
$525.1M
Q2 25
$544.0M
$344.2M
Q1 25
$314.0M
$441.7M
Q4 24
$464.0M
$578.9M
Q3 24
$356.0M
$277.9M
Q2 24
$360.0M
$230.9M
Free Cash Flow
DGX
DGX
FTI
FTI
Q1 26
Q4 25
$307.0M
$359.1M
Q3 25
$419.0M
$447.8M
Q2 25
$436.0M
$260.6M
Q1 25
$197.0M
$379.9M
Q4 24
$341.0M
$452.7M
Q3 24
$250.0M
$225.3M
Q2 24
$268.0M
$180.1M
FCF Margin
DGX
DGX
FTI
FTI
Q1 26
Q4 25
10.9%
14.3%
Q3 25
14.9%
16.9%
Q2 25
15.8%
10.3%
Q1 25
7.4%
17.0%
Q4 24
13.0%
19.1%
Q3 24
10.0%
9.6%
Q2 24
11.2%
7.7%
Capex Intensity
DGX
DGX
FTI
FTI
Q1 26
3.9%
Q4 25
5.6%
3.8%
Q3 25
5.1%
2.9%
Q2 25
3.9%
3.3%
Q1 25
4.4%
2.8%
Q4 24
4.7%
5.3%
Q3 24
4.3%
2.2%
Q2 24
3.8%
2.2%
Cash Conversion
DGX
DGX
FTI
FTI
Q1 26
0.99×
Q4 25
1.90×
1.87×
Q3 25
2.30×
1.70×
Q2 25
1.93×
1.28×
Q1 25
1.43×
3.11×
Q4 24
2.09×
2.58×
Q3 24
1.58×
1.01×
Q2 24
1.57×
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGX
DGX

Segment breakdown not available.

FTI
FTI

Services$1.3B52%
Products$1.1B44%
Other$55.1M2%
Surface Technologies$22.4M1%

Related Comparisons